Xcout Intel
Frontier Medicines Corp competitors & alternatives
The 12 closest competitors and alternatives to Frontier Medicines Corp among biotech companies — ranked by similarity to what Frontier Medicines Corp actually does, not by market-cap band.
Subscribe to see Frontier Medicines Corp’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Frontier Medicines Corp
Frontier Medicines, Corp. is a precision medicine company focusing on drug development with offices in locations including South San Francisco, California, and Boston.
Frontier Medicines Corp at a glance
Frontier Medicines Corp is a biotech company headquartered in United States, founded in 2018. It has raised at least $155.5M across the 2 funding rounds on record. Its most recent funding round raised $88.5M in June 2021. Xcout tracks 1 named person at Frontier Medicines Corp, including Chris Varma, Ph.D. (Co-founder, Chairman and CEO). Xcout recorded 8 job postings from Frontier Medicines Corp in the last 90 days.
Frontier Medicines Corp leadership
- Chris Varma, Ph.D.Co-founder, Chairman and CEO
Frontier Medicines Corp funding rounds
At least $155.5M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $88.5M | — | |
| — | $67M | 8 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Frontier Medicines Corp
Xcout recorded 8 job postings from Frontier Medicines Corp in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Frontier Medicines Corp's hiring signals →
Top 12 Frontier Medicines Corp competitors
Ranked by semantic similarity — how close each company is to Frontier Medicines Corp by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Gordian Biotechnology is a biotechnology research company headquartered in South San Francisco, California. The company focuses on curing age-related diseases through in vivo target discovery and functional genomics platforms.
Biotechnology
Tessellate Bio is a biotechnology company that develops precision oncology medicines by exploring synthetic lethal interactions beyond homologous recombination deficiency. The company integrates biomarker discovery and companion diagnostics into its research programs to create first-in-class treatments for hard-to-treat cancers.
Biotechnology
Fauna Bio is a biotechnology company headquartered in Berkeley, California. The company combines animal genomics and advanced data approaches to drive drug discovery and improve human health.
Biotechnology
Relay Therapeutics, Inc. is a precision medicine company currently engaged in clinical trials. Its central mission involves revolutionizing the drug discovery process, with a particular focus on enhancing the creation of small molecule therapies for specific types of cancer and genetic conditions. The company's pipeline features several promising drug candidates: RLY-4008, an orally administered small molecule designed to inhibit fibroblast growth factor receptor 2 (FGFR2), which is undergoing its initial human trials for patients with advanced or metastatic solid tumors exhibiting FGFR2 alterations; RLY-2608, a leading program targeting mutant phosphoinositide 3 kinase alpha (PI3Ka); and RLY-1971, another oral small molecule, an inhibitor of SHP2 (protein tyrosine phosphatase Src homology region 2 domain-containing phosphatase-2), currently in Phase 1 trials for individuals with advanced solid tumors. Relay Therapeutics has established strategic partnerships, including a collaboration with D. E. Shaw Research, LLC, which utilizes computational modeling to analyze protein motion for the identification and development of therapeutic compounds. Furthermore, an agreement with Genentech, Inc. supports the development and commercialization of RLY-1971. Founded in 2015 as Allostery, Inc., the company rebranded to Relay Therapeutics, Inc. in December of that year and maintains its headquarters in Cambridge, Massachusetts.
Similar biotech company
Monte Rosa Therapeutics, Inc. is a biopharmaceutical company dedicated to pioneering novel, small-molecule precision medicines. Their core approach involves leveraging the body's inherent mechanisms to precisely eliminate therapeutically relevant proteins. Among their key initiatives is an oral molecular glue degrader designed to target GSPT1, a specific translational termination factor and degron-containing protein, with the aim of treating Myc-driven cancers. The company's pipeline further includes programs for CDK2 in ovarian, uterine, and breast cancers, alongside NEK7 for addressing a spectrum of inflammatory conditions such as Crohn's disease, neurodegenerative ailments, diabetes, and liver disease. Moreover, VAV1 is being explored as a target for autoimmune disorders, and BCL11A, a protein holding significant therapeutic relevance, is under investigation for hemoglobinopathies. Founded in 2019, Monte Rosa Therapeutics, Inc. operates from its headquarters in Boston, Massachusetts.
Similar biotech company
Volastra Therapeutics, Inc. is a U.S. biotechnology company developing cancer medicines designed to prevent or treat metastasis, the spread of tumors to other parts of the body. It uses functional genomics and related technologies to discover therapeutic targets and serves the oncology and biopharmaceutical markets.
Biotechnology
BreezeBio is a biotechnology company headquartered in the South San Francisco area of California that develops precision genetic medicines.
Similar biotech company
Mirador Therapeutics, Inc. is a clinical-stage precision medicine company headquartered in San Diego, California, focused on developing first- and best-in-class next-generation therapeutics.
Biotechnology
Tyra Biosciences is a biotechnology company headquartered in Carlsbad, California, that develops next-generation precision medicines.
Similar biotech company
Blueprint Medicines Corporation is a global precision therapy company that invents life-changing medicines, operating as a Sanofi company.
Similar biotech company
Expedition Medicines, Inc. is a biotechnology company founded in 2022 and headquartered in Cambridge, Massachusetts, focused on generatively designing novel drugs targeting specific proteins.
Similar biotech company
NGM Biopharmaceuticals, Inc. is a clinical-stage biotechnology company headquartered in South San Francisco, California, focused on discovering and developing transformative therapeutics.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Frontier Medicines Corp and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Frontier Medicines Corpand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →